Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Yumiko Nakamura

Dados Biográficos

ID7966992
NOMEYumiko Nakamura
PRENOMESYumiko
SOBRENOMENakamura
ASSINATURANAKAMURA Y
AFILIAÇÕESUniversity of Toyama
ORCID0000-0002-3440-1641
VERIFICADOSim
TOTAL DE OBRAS2
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2013
ANO MAIS RECENTE DE PUBLICAÇÃO2019
ÍNDICE H0
  • Eculizumab improves fatigue in refractory generalized myasthenia gravis

    Open Access•Henning Andersen, Renato Mantegazza et al.•ARTICLE•Quality of Life Research•2019

    Compared with placebo, eculizumab was associated with improvements in perceived fatigue that strongly correlated with improvements in MG-specific outcome measures. Trial ID Registration: NCT01997229, NCT02301624

  • Gray Matter Changes in Subjects at High Risk for Developing Psychosis and First-Episode Schizophrenia

    Open Access•Kazue Nakamura, Tsutomu Takahashi et al.•ARTICLE•Frontiers in Psychiatry•2013

    The present study suggests that alteration of the anterior cingulate gyrus may be associated with development of frank psychosis. Further studies with a larger ARMS subjects would be required to examine the potential role of neuroimaging methods in the prediction of future transition into psychosis

Sem obras proeminentes nesta página.

  • Gray Matter Changes in Subjects at High Risk for Developing Psychosis and First-Episode Schizophrenia

    Open Access•Kazue Nakamura, Tsutomu Takahashi et al.•ARTICLE•Frontiers in Psychiatry•2013

    The present study suggests that alteration of the anterior cingulate gyrus may be associated with development of frank psychosis. Further studies with a larger ARMS subjects would be required to examine the potential role of neuroimaging methods in the prediction of future transition into psychosis

  • Eculizumab improves fatigue in refractory generalized myasthenia gravis

    Open Access•Henning Andersen, Renato Mantegazza et al.•ARTICLE•Quality of Life Research•2019

    Compared with placebo, eculizumab was associated with improvements in perceived fatigue that strongly correlated with improvements in MG-specific outcome measures. Trial ID Registration: NCT01997229, NCT02301624

Medicine (2 obras) · Advanced Neuroimaging Techniques and Applications (1 obras) · Anterior cingulate cortex (1 obras) · Antibody (1 obras) · At risk mental state (1 obras) · Cognition (1 obras) · Complement system (1 obras) · Eculizumab (1 obras) · Functional Brain Connectivity Studies (1 obras) · Gray (unit (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae